Stem cell study reveals cells' capability in mouse brain tissue repair

UCSF scientists have determined that adult stem cells in a specific region of the mouse brain have a built-in mechanism that allows the cells to participate in the repair and remodeling of damaged tissue in the region.

As the cells are also present in the human brain, the same capacity or potential may exist in humans, the researchers say. If they do, it is possible that the cells’ behavior could be enhanced to treat tissues damaged throughout the brain by disorders such as stroke and traumatic injury.

The study, reported in the December 15 issue of Cell, was led by Chay T. Kuo, MD, PhD, a UCSF postdoctoral fellow in the laboratory of senior investigator Yuh-Nung Jan, PhD.

Kuo is one of 16 UCSF CIRM Stem Cell Scholars – up and coming young scientists funded by the California Institute for Regeneration Medicine, established by California voters in 2004 to allocate $3 billion over 10 years to support stem cell research.

"The results were very surprising," says Kuo. "Our results show that neural stem cells in mice have the ability to sense damage in their environment that leads to their subsequent proliferation to help restore local tissue integrity. If we can figure out how this happens, and determine that it occurs in human neural stem cells, we may be able to increase the effect and harness it for therapeutic use."

Understanding this proliferative capacity during environmental change is critical, he says, as adult neural stem cells in this region may sometimes proliferate out of control to form brain tumors. This possibility has been reported and is being explored by scientists in the UCSF Institute for Regeneration Medicine and UCSF Department of Neurological Surgery.

The scientists focused their study on postnatal neural stem cells that lie next to the lining of the brain’s lateral ventricles, or cavity, in a region known as the subventricular zone (SVZ). In 1999, the lab of study co-author Arturo Alvarez-Buylla, PhD, UCSF Heather and Melanie Muss Professor of Neurological Surgery, discovered that cells in this region known as astrocytes function as adult neural stem cells in mice (Cell, June 11, 1999) and later discovered similar cells within the human brain (Nature, Feb. 19, 2004). The cells are recognized as a major source of adult stem cells in the mammalian brain.

Scientists have known that neural stem cells play a key role in both embryonic and postnatal mice, driving the development of specialized cells within the brain such as neurons, astrocytes, oligodendrocytes, and ependymal cells. And they have identified many of the molecular pathways that control neural stem cell behavior in embryonic mice.

But relatively little was known about the molecular programs that control neural stem cells in the postnatal mouse, or how neural stem cells may respond to tissue damage -- two key questions for scientists exploring the potential of these cells to treat disease.

To shed light on these issues, Kuo and his colleagues genetically engineered neural stem cells and ependymal cells in the SVZ of newborn mice in such a way that they lacked two key proteins, named Numb and Numblike.

These proteins are known to play a critical role in maintaining neural stem cell function in embryonic mice, but scientists have not known their actual function. They suspected that the proteins might be active in the SVZ of postnatal mice as well. If so, they reasoned, preventing the proteins’ synthesis might inhibit the cells’ local activity and, in so doing, reveal their postnatal function. At the same time, if the cells’ activity was inhibited by the absence of the proteins, there could be tissue damage in the SVZ, providing a model for exploring the way in which the neural stem cells responded to it.

The strategy paid off.

Kuo and his colleagues’ examination of postnatal mouse brains on autopsy seven and 14 days after the genetic modification revealed that absence of proteins Numb and Numblike led to severe brain ventricle enlargement. This defect resulted from damage of ependymal cells, which form the epithelial lining of the brain ventricles, and of neuroblasts, which evolve into neurons. Thus, it was evident that, as in embryonic mice, the proteins play a crucial role in the maintenance of cells in the region, and revealed a previously unknown function for them in assuring ependymal layer integrity.

Wholly unexpected, however, was the fact that damage to the left ventricular wall was substantially repaired when these sick mice were examined six weeks later. As a result of a known limitation of the genetic engineering technique that Kuo employed – some neural stem cells escaped gene deletion, thus allowing the Numb protein they synthesized to remain intact – some neural stem cells had continued to function. Faced with damage in the region, these cells had responded, mediating the rebuilding of ventricular wall lining and establishing a modified neural stem cell environment.

The scientists do not know the precise mechanisms by which the stem cells carried out their response. But it was astonishing, says study senior investigator Jan, who is , a Howard Hughes Medical Institute investigator, the Jack and DeLoris Lange Endowed Chair in Molecular Physiology and professor of physiology and biochemistry at UCSF.

"The holes that had formed in the brain ventricular wall had largely been repaired. These adolescent mice looked quite good. The finding shows that the brain has the ability to repair itself and that it is more plastic than previously appreciated."

The model Kuo devised, says Jan, will provide a powerful tool for studying the response of neural stem cells of the SVZ to damage caused by such conditions as stroke and trauma.

It can also be used to test the impact of deleting various genes from neural stem cells of the SVZ. The results, he says, would contribute to scientists’ understanding of the full pathway of genes needed to prompt differentiation of neural stem cells both in the brain and in the culture dish. In this sense, he says, "the deletion of Numb and Numblike was a test case."

In collaboration with other UCSF neuroscientists, as well as neurosurgeons, Kuo is currently exploring whether neural stem cells of the SVZ can respond to damage outside the ventricle region and, if so, whether inflammation in the traumatized area prevents the stem cells from restoring the tissue.

And he wonders whether the epilepsy that can occur in stroke and trauma patients, often years after the injury, results from unsuccessful attempts by the progeny of neural stem cells to make synaptic connections with other cells in the damaged region.

Numerous other UCSF labs are also investigating neural stem cells in the SVZ of the embryonic and postnatal brain, with an eye toward developing therapies for Parkinson’s, epilepsy and ALS, says Arnold Kriegstein, MD, PhD, the John G. Bowes Endowed Chair in Stem Cell and Tissue Biology and director of the UCSF Institute for Regeneration Medicine.

And like the neural stem cells they study, these scientists are collaborating, making connections aimed at building new material. "As such," says Kriegstein, "their work demonstrates the power of synergy."

Source: University of California - San Francisco

Related stories:

Researchers link early stem cell mutation to autism
In a breakthrough scientific study published today in the Proceedings of the National Academy of Sciences, scientists at the Burnham Institute for Medical Research have shown that neural stem cell development may be linked to Autism. The study demonstrated that mice lacking the myocyte enhancer factor 2C (MEF2C) protein in neural stem cells had smaller brains, fewer nerve cells and showed behaviors similar to those seen in humans with a form of autism known as Rett Syndrome.
Reprogramming Adult Stem Cells in the Brain
In recent years, stem cell researchers have become very adept at manipulating the fate of adult stem cells cultured in the lab. Now, researchers at the Salk Institute for Biological Studies achieved the same feat with adult neural stem cells still in place in the brain. They successfully coaxed mouse brain stem cells bound to join the neuronal network to differentiate into support cells instead.
Nerve cells derived from stem cells and transplanted into mice may lead to improved brain treatments
Scientists at the Burnham Institute for Medical Research have, for the first time, genetically programmed embryonic stem (ES) cells to become nerve cells when transplanted into the brain, according to a study published today in The Journal of Neuroscience. The research, an important step toward developing new treatments for stroke, Alzheimer's, Parkinson's and other neurological conditions showed that mice afflicted by stroke showed tangible therapeutic improvement following transplantation of these cells. None of the mice formed tumors, which had been a major setback in prior attempts at stem cell transplantation.
Researchers show how the brain can protect against cancer
Scientists have been aware for many years that if cancer patients are not able to deal with the stress associated with being sick, the cancer will progress faster than in calmer patients. To counteract this phenomenon, physicians encourage treatments that help cancer patients handle their stress. Scientists theorized that the stress relief may have come as a result of increased beta-endorphin peptide (BEP), the "feel good" hormones in the brain that are released during exercise, a good conversation, and many other aspects of life that give humans pleasure.
Mixing and matching genes to keep nerve cells straight
With fewer than 30,000 human genes with which to work, Nature has to mix and match to generate the myriad types of neurons or nerve cells needed to assemble the brain and nervous system. Keeping this involved process on the straight and narrow requires a clever balance of promotion and inhibition, said researchers from Baylor College of Medicine in Houston in a report that appears in the current edition of the journal Developmental Cell.
Brain stem cells can be awakened, say scientists
Scientists at Schepens Eye Research Institute have identified specific molecules in the brain that are responsible for awakening and putting to sleep brain stem cells, which, when activated, can transform into neurons (nerve cells) and repair damaged brain tissue. Their findings are published online this week in the Proceedings of the National Academy of Science (PNAS).
Neurologically impaired mice improve after receiving human stem cells
Scientists report a dramatic success in what may be the first documented rescue of a congenital brain disorder by transplantation of human neural stem cells. The research, published by Cell Press in the June issue of the journal Cell Stem Cell, may lead the way to new strategies for treating certain hereditary and perinatal neurological disorders.
Mammalian neurogenesis breaks into the most static brain region
Fifteen years ago, the discovery of adult neurogenesis (the production of new neurons) in the highly static, non-renewable mammalian brain was a breakthrough in neuroscience. Most emphasis was put on the possibility to figure out new strategies for brain repair against the threath of neurodegenerative diseases. Yet, unlike lower vetebrates, which are characterized by widespread postnatal neurogenesis, neurogenic sites in mammals are highly restricted within two very small regions. Hence, the fact that protracted neurogenesis in mammals is an exception rather than the rule slowes down hopes for generalized brain repair.

News discussion:

Medicine & Health news